Legal & General Group PLC Embecta Corp. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Embecta Corp. stock. As of the latest transaction made, Legal & General Group PLC holds 154,838 shares of EMBC stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

154,838

Previous 154,838 -0.0%

Holding current value

$2.26 Million

Previous $2.18 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.46 - $16.56 $37,451 - $54,118	-3,268 Reduced 2.07%	154,838 $2.18 Million
Q2 2024 Aug 14, 2024	BUY	$10.13 - $14.6 $10,707 - $15,432	1,057 Added 0.67%	158,106 $1.98 Million
Q1 2024 May 14, 2024	BUY	$12.35 - $19.33 $10,497 - $16,430	850 Added 0.54%	157,049 $2.08 Million
Q4 2023 Feb 15, 2024	SELL	$12.87 - $19.09 $14,041 - $20,827	-1,091 Reduced 0.69%	156,199 $2.96 Million
Q3 2023 Nov 14, 2023	SELL	$15.0 - $22.17 $76,710 - $113,377	-5,114 Reduced 3.15%	157,290 $2.37 Million
Q2 2023 Aug 14, 2023	SELL	$21.6 - $30.69 $160,488 - $228,026	-7,430 Reduced 4.37%	162,404 $3.51 Million
Q1 2023 May 15, 2023	SELL	$23.07 - $32.77 $63,996 - $90,903	-2,774 Reduced 1.61%	169,834 $4.78 Million
Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $155,255 - $217,811	6,139 Added 3.69%	172,608 $4.37 Million
Q3 2022 Nov 14, 2022	SELL	$24.0 - $33.42 $3.41 Million - $4.75 Million	-142,011 Reduced 46.04%	166,469 $4.8 Million
Q2 2022 Aug 22, 2022	BUY	$24.78 - $33.36 $7.56 Million - $10.2 Million	304,905 Added 8528.81%	308,480 $7.81 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $47.0 $119,154 - $168,025	3,575 New	3,575 $119,000

Others Institutions Holding EMBC

# of Institutions

403

Shares Held

51.2M

Call Options Held

162K

Put Options Held

61K

View Full List

About Embecta Corp.

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $846M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

More about EMBC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Embecta Corp. Transaction History